Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coblopasvir + Sofosbuvir in Chronic Hepatitis C
NCT03995485Phase 3Completed
- Sponsor
- Beijing Kawin Technology Share-Holding Co., Ltd.
- Start
- Jun 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of coblopasvir in hepatitis C (HCV), sponsored by Beijing Kawin Technology Share-Holding Co., Ltd.. Started Jun 2017; status: completed.
02
Drugs
coblopasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03995485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03995485.